GURU.Markets stock price, segment price, and overall market index valuation
The company's share price QuidelOrtho
The merger resulted in QuidelOrtho, a major medical diagnostics company. Its share price reflects both the robust demand for its lab tests and the sharp decline in revenue from COVID-19 tests, which had been its primary growth driver.
Share prices of companies in the market segment - Medanalysis
QuidelOrtho is a merger company with segments in infectious disease diagnostics and laboratory diagnostics. We classify it as part of the Medanalysis sector, and the chart below reflects the dynamics of the entire industry, as well as the integration history of the two companies.
Broad Market Index - GURU.Markets
QuidelOrtho is a diagnostics company that produces tests for infectious diseases, cardiac markers, and other conditions. It is a component of the GURU.Markets index. The chart below represents the market. See how QuidelOrtho shares compare to the healthcare sector.
Change in the price of a company, segment, and market as a whole per day
QDEL - Daily change in the company's share price QuidelOrtho
Daily fluctuations in QuidelOrtho, a diagnostic testing manufacturer, reflect volatility in the healthcare sector. change_co measures sensitivity to testing demand and seasonal fluctuations. This metric is important for analyzing companies in the medical diagnostics sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
QuidelOrtho Corporation is a major player in the medical diagnostics market. This chart shows the sector's average daily volatility. Comparing it to QDEL, with its broad portfolio of tests, helps assess its stability compared to companies dependent on a single product.
Daily change in the price of a broad market stock, index - GURU.Markets
QuidelOrtho is a medical diagnostics company formed through a merger. Its business depends on demand for tests, which can be volatile, as demonstrated by the pandemic. The chart below shows overall market volatility, providing context for QuidelOrtho's valuation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization QuidelOrtho
QuidelOrtho, a diagnostic equipment manufacturer, has adapted to post-pandemic demand over the past year. Its year-over-year share price performance, shown in the chart, reflects its growth efforts in its core business, unrelated to COVID-19.
Annual dynamics of market capitalization of the market segment - Medanalysis
QuidelOrtho Corporation is a global diagnostics company. Following the merger, its goal is to successfully integrate its businesses and realize synergies. The chart below shows how the market is viewing the deal and how its diversified testing portfolio is responding to changes in demand post-pandemic.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
QuidelOrtho, a diagnostic testing maker, is experiencing a post-pandemic recovery. Its stock price reflects the decline in demand for COVID-19 tests and a return to normal, more stable business. This chart tells the story of how the company is adapting to life after the unprecedented boom caused by the global crisis.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization QuidelOrtho
QuidelOrtho, a company formed through the merger of diagnostic equipment manufacturers, has monthly fluctuations on the chart reflecting demand for its tests, especially after the sharp decline in demand for COVID-19 tests.
Monthly dynamics of market capitalization of the market segment - Medanalysis
This chart reflects the dynamics of the molecular diagnostics sector. For QuidelOrtho, the merger that resulted, it serves as a backdrop. Its movements demonstrate how the company is adapting to the sharp decline in demand for COVID-19 tests and increasing sales in other segments.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
QuidelOrtho produces diagnostic equipment and tests. Demand for its products can surge during epidemics, as seen with COVID-19. This makes its stock event-driven. While the company typically follows healthcare trends, its performance can diverge sharply from the market when new health threats emerge.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization QuidelOrtho
QuidelOrtho Corporation produces diagnostic tests used in hospitals and laboratories. Its weekly stock price performance following the COVID-19 testing boom during the pandemic depends on demand for its core product portfolio and its ability to develop and market new diagnostic solutions.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Following the pandemic boom, QuidelOrtho is struggling to find its place in the diagnostics sector. Investors are comparing its performance with competitors to assess how successfully it is replacing revenue from COVID testing. The chart shows whether it is lagging behind the sector or finding new growth drivers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
QuidelOrtho produces medical diagnostic equipment. Demand for its products, which surged during the pandemic, is now returning to normal. The chart will show how the company is adapting to the post-pandemic reality and how volatile its stock is compared to the market.
Market capitalization of the company, segment and market as a whole
QDEL - Market capitalization of the company QuidelOrtho
The market capitalization chart of QuidelOrtho, the merger's result, reflects its position in the diagnostic testing market. The sharp rise during the pandemic was attributed to its COVID-19 tests. The subsequent performance shows how investors assess its ability to grow in a post-pandemic world through its core product portfolio.
QDEL - Share of the company's market capitalization QuidelOrtho within the market segment - Medanalysis
QuidelOrtho, formed as a result of the merger, has become a major player in the diagnostics market, holding significant shares in both rapid tests and laboratory testing. Its market capitalization reflects the synergies generated by the combination of these two businesses.
Market capitalization of the market segment - Medanalysis
Here's a chart showing the market capitalization of the medical diagnostics sector. QuidelOrtho is a major player formed through a merger, with strong positions in rapid testing and laboratory diagnostics. The dynamics of this market reflect both routine healthcare needs and pandemic preparedness, where rapid testing plays a key role.
Market capitalization of all companies included in a broad market index - GURU.Markets
QuidelOrtho produces diagnostic tests for hospitals and home use. Its market capitalization reflects the importance of rapid and accurate diagnostics in modern medicine. The chart below shows the economic weight of the medical testing and laboratory industry.
Book value capitalization of the company, segment and market as a whole
QDEL - Book value capitalization of the company QuidelOrtho
QuidelOrtho's book value is derived from its factories producing diagnostic equipment and tests for laboratories and point-of-care services. This chart tells the story of a company formed through a merger, managing a diversified portfolio of assets and seeking to extract synergies in a post-pandemic world.
QDEL - Share of the company's book capitalization QuidelOrtho within the market segment - Medanalysis
QuidelOrtho produces diagnostic tests. The chart shows its share of real assets. These include its factories and R&D centers, which develop and produce tests for hospitals and home use, playing a key role in health monitoring.
Market segment balance sheet capitalization - Medanalysis
QuidelOrtho is a major manufacturer of diagnostic tests and equipment. This is a capital-intensive business, requiring manufacturing facilities around the world to produce reagents and devices, as well as an extensive R&D base. Compared to the healthcare sector, it is a heavyweight in the diagnostics industry.
Book value of all companies included in the broad market index - GURU.Markets
QuidelOrtho's assets comprise a global network of diagnostic test manufacturers, ranging from rapid flu tests to sophisticated blood analysis equipment. The company's balance sheet reflects its robust manufacturing and research capabilities. The chart below shows the capital behind the infrastructure necessary for rapid and accurate diagnostics.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - QuidelOrtho
QuidelOrtho produces diagnostic equipment and tests. Its value lies not only in its manufacturing facilities but also in its portfolio of approved tests, its installed base of devices in hospitals, and its ability to rapidly develop new tests (as was the case with COVID-19). Its market capitalization reflects this innovative and scientific potential.
Market to book capitalization ratio in a market segment - Medanalysis
QuidelOrtho is a major diagnostic testing company. The company combines manufacturing capabilities and intellectual property. This chart shows how the market values its product portfolio, balancing stable revenue from routine testing with the potential for new diagnostic solutions.
Market to book capitalization ratio for the market as a whole
QuidelOrtho is a company specializing in diagnostic testing. Its value is determined by both its existing product portfolio and its ability to develop new tests. This chart shows how the market values a healthcare company that combines manufacturing capabilities and intellectual property.
Debts of the company, segment and market as a whole
QDEL - Company debts QuidelOrtho
QuidelOrtho is a leading manufacturer of diagnostic tests. The company's growth is fueled by both the development of new tests and strategic acquisitions. Debt financing is an important tool, allowing the company to invest in research, expand production capacity, and integrate acquired businesses.
Market segment debts - Medanalysis
QuidelOrtho, the company formed as a result of the merger, is a major player in the medical diagnostics market. The company's debt load is largely a legacy of this transaction. This chart shows how the company is managing its debt while integrating the two businesses and seeking to realize synergies to increase cash flow and reduce leverage.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio QuidelOrtho
QuidelOrtho is a major diagnostic testing manufacturer. This chart shows its financial structure after a major merger and the end of the pandemic boom. The debt level here reflects the financing of the deal and the company's efforts to integrate its businesses and find new growth drivers in the diagnostics market following the sharp decline in demand for COVID-19 tests.
Market segment debt to market segment book capitalization - Medanalysis
QuidelOrtho produces diagnostic tests for various diseases. The chart below shows the overall debt position in the medical diagnostics sector. It helps understand how the company uses debt capital to fund research and development of new tests, as well as to compete in a market where speed and diagnostic accuracy are crucial.
Debt to book value of all companies in the market
QuidelOrtho, a diagnostic testing manufacturer, operates in the healthcare sector. The chart shows the overall debt policy for the entire economy. It helps understand how the medical diagnostics sector, whose demand can fluctuate dramatically (as during the pandemic), follows or deviates from overall economic trends.
P/E of the company, segment and market as a whole
P/E - QuidelOrtho
For QuidelOrtho, a diagnostic equipment manufacturer, this chart is a story of life after the pandemic. The huge revenues from COVID-19 tests are gone, and investors' estimates of the company's profits now depend on its core business. The dynamics show whether the market believes the company can grow without the extraordinary demand caused by the global pandemic.
P/E of the market segment - Medanalysis
This chart shows the average valuation for the medical diagnostics sector—the benchmark for QuidelOrtho. Comparing the company's post-pandemic valuation to the industry average clearly demonstrates how investors assess its ability to grow without COVID testing revenue. A valuation below the average indicates skepticism about its core business.
P/E of the market as a whole
QuidelOrtho produces diagnostic tests, from rapid flu and COVID-19 tests to sophisticated lab equipment. Following the pandemic boom, the company is adapting to the new reality. This chart of overall healthcare sentiment helps understand how investors view the future of diagnostics, whether they believe in stable demand or fear a sharp decline in revenue post-COVID.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company QuidelOrtho
QuidelOrtho produces diagnostic tests for hospitals, laboratories, and home use. Following the COVID-19 testing boom, the company is seeking new growth drivers. This chart reflects analysts' expectations regarding future demand for diagnostics for other diseases and the success of the integration of Quidel and Ortho.
%20P%2FE%20QuidelOrtho&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-QuidelOrtho&v=1772513692449 "Chart of the company's future (projected) P/E QuidelOrtho")
Future (projected) P/E of the market segment - Medanalysis
QuidelOrtho is a company that develops and manufactures diagnostic tests. Its valuation relative to other companies in the medical diagnostics industry reflects investors' opinions on its ability to grow following the COVID-19 pandemic, which has generated significant revenue from its testing. This demonstrates investors' confidence in its core business and new products.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772513692472 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
QuidelOrtho produces diagnostic tests for various diseases. The company received a huge boost during the COVID-19 pandemic. Now, its goal is to find new growth drivers. This chart shows the overall market sentiment that influences the valuation of companies in the healthcare sector. It helps understand how investors view the diagnostics market prospects post-pandemic.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513692489 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit QuidelOrtho
QuidelOrtho, the merged company, produces diagnostic tests for hospitals, laboratories, and home use. The financial results presented here reflect demand for its tests, which can fluctuate significantly depending on the respiratory season and epidemiological situation.
Profit of companies in the market segment - Medanalysis
QuidelOrtho, the company formed as a result of the merger, is a major player in the medical diagnostics market, covering everything from COVID-19 tests to laboratory equipment. This chart shows the overall profitability of the medical diagnostics sector. It demonstrates how the decline in pandemic demand and the rise of elective care are impacting the financial performance of the entire industry.
Overall market profit
QuidelOrtho specializes in diagnostic solutions, from rapid flu tests to sophisticated lab equipment. Following a surge in demand during the pandemic, the company is adapting to the new reality. Its core business relies on testing volumes in hospitals, which are less susceptible to the economic cycles reflected in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company QuidelOrtho
QuidelOrtho produces diagnostic tests for various diseases. Following a huge surge in demand during the COVID-19 pandemic, the company is in the process of normalizing its business. Its future profit forecast reflects analysts' expectations for demand for its core products and the company's ability to find new sources of growth after the pandemic boom subsides.
%20profit%20of%20the%20company%20QuidelOrtho&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-QuidelOrtho&v=1772513692548 "Graph of future (projected) profit of the company QuidelOrtho")
Future (predicted) profit of companies in the market segment - Medanalysis
QuidelOrtho, formed from the merger of Quidel and Ortho Clinical Diagnostics, is a major player in the medical diagnostics market. The company produces tests and equipment for laboratories, hospitals, and home use. This chart shows forecasts for the medical testing sector. It helps assess how the company is adapting to the decline in demand for COVID tests and developing other areas.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772513692554 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
QuidelOrtho produces diagnostic tests for hospitals, laboratories, and home use. Demand for many of its products, particularly for infectious diseases, doesn't always correlate with economic cycles, as reflected in this chart. However, the overall economic situation impacts healthcare budgets and routine testing, which can affect some of the company's business.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513692582 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - QuidelOrtho
QuidelOrtho produces diagnostic tests, including COVID-19 tests, which have generated significant revenue. This chart shows how investors assess its ability to sustain sales post-pandemic by expanding into other infectious disease diagnostic products.
P/S market segment - Medanalysis
QuidelOrtho, the merger of Quidel and Ortho Clinical Diagnostics, is a global leader in diagnostic testing. This chart shows the average valuation in the medical analytics sector. It helps understand how investors view the synergies from the merger and the company's broad portfolio of products for hospitals, laboratories, and home use.
P/S of the market as a whole
QuidelOrtho Corporation produces diagnostic tests for hospitals, laboratories, and home use, including infectious disease tests, cardiac markers, and more. Revenue depends on demand for diagnostics. This chart helps investors assess how the market views the medical testing company after the pandemic boom.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company QuidelOrtho
QuidelOrtho is a diagnostic equipment and testing company. Its future revenue depends on demand for diagnostics in both hospitals and point-of-care settings. The chart reflects investor expectations regarding testing volumes after the pandemic and the success of the integration of the two combined companies.
%20P%2FS%20QuidelOrtho&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-QuidelOrtho&v=1772513692656 "The graph of the company's future (projected) P/S QuidelOrtho")
Future (projected) P/S of the market segment - Medanalysis
QuidelOrtho produces diagnostic tests for hospitals, laboratories, and home use. The company is best known for its COVID-19 tests, but also has a wide portfolio of tests for other diseases. This chart shows how the market estimates its future sales after the pandemic, compared to other companies in the medical diagnostics sector.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772513692685 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Market sentiment, as reflected in this chart, is important for medical diagnostics. For QuidelOrtho, a diagnostic test maker, it's an indicator of healthcare spending. Market optimism supports stable funding for hospitals and laboratories, which are the primary customers for the company's tests for a wide range of diseases.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513692700 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales QuidelOrtho
QuidelOrtho, the merger of Quidel and Ortho Clinical Diagnostics, is a global provider of in vitro diagnostic solutions. This chart shows revenue from sales of diagnostic tests and equipment for laboratories and hospitals. Its dynamics reflect the demand for testing for various diseases, from infectious diseases to cardiac ones.
Sales of companies in the market segment - Medanalysis
QuidelOrtho, the merger of Quidel and Ortho Clinical Diagnostics, is a major player in the in vitro diagnostics market. This chart shows growth in the medical analytics sector. QuidelOrtho produces tests and equipment for hospitals, laboratories, and home use, playing a key role in disease diagnosis.
Overall market sales
QuidelOrtho Corporation produces diagnostic tests for various diseases. Demand for its products depends on testing volumes in hospitals and laboratories. The overall economic situation, shown in this graph, influences healthcare budgets and the frequency of doctor visits, which drives the underlying demand for the company's diagnostic solutions.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company QuidelOrtho
QuidelOrtho, the merger of Quidel and Ortho Clinical Diagnostics, is a major player in the in vitro diagnostics market. It produces tests and equipment for laboratories and rapid diagnostics. This chart reflects analyst forecasts for the diagnostic services market, taking into account both the post-COVID decline in demand for tests and growth in other areas.
%20sales%20of%20the%20company%20QuidelOrtho&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-QuidelOrtho&v=1772513692800 "Schedule of future (projected) sales of the company QuidelOrtho")
Future (projected) sales of companies in the market segment - Medanalysis
QuidelOrtho produces diagnostic tests for infectious diseases, cardiac markers, and other conditions. This forecast provides insight into the expectations for the healthcare analytics sector. It reflects the global demand for fast and accurate diagnostics in both hospitals and at-home settings, which is key to the company's business.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772513692805 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
QuidelOrtho Corporation produces diagnostic tests for a variety of conditions, from infectious diseases to cardiac ones. Demand for its products depends on testing volumes in hospitals and laboratories. The overall economic situation, shown in this graph, influences healthcare budgets and routine examinations, which drives demand for the company's diagnostic solutions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513692824 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality QuidelOrtho
QuidelOrtho is a major manufacturer of diagnostic tests, from rapid flu tests to sophisticated lab equipment. This chart shows profitability in the medical diagnostics industry. The company's profit depends on test sales volumes, especially during seasonal flu seasons, and on its ability to bring new diagnostic solutions to market.
Market segment marginality - Medanalysis
QuidelOrtho is a major player in the in vitro diagnostics market, offering tests for infectious diseases, cardiology, and other areas. Profitability depends on test and equipment sales volumes. This chart shows the company's operating efficiency after the merger of Quidel and Ortho Clinical Diagnostics, compared to other medical diagnostics giants.
Market marginality as a whole
QuidelOrtho produces diagnostic tests for a variety of conditions, from infectious diseases to cardiac ones. This overall market profitability chart isn't key for the company. Demand for its products is driven by healthcare system needs, disease outbreaks, and demographic trends. Its margins depend on innovation and manufacturing efficiency.
Employees in the company, segment and market as a whole
Number of employees in the company QuidelOrtho
QuidelOrtho, the company formed from the merger of Quidel and Ortho Clinical Diagnostics, is a major player in the medical testing and diagnostic equipment market. The chart shows the combined team. The staffing changes may reflect integration and synergies following the merger.
Share of the company's employees QuidelOrtho within the market segment - Medanalysis
QuidelOrtho is a major player in the in vitro diagnostics market, formed by the merger of Quidel and Ortho Clinical Diagnostics. This chart shows the company's weight as a global employer in the medical device sector. It reflects the significant share of scientists, engineers, and manufacturing personnel working on the development of diagnostic tests and equipment.
Number of employees in the market segment - Medanalysis
QuidelOrtho Corporation is a global provider of innovative diagnostic solutions. The company was formed through the merger of Quidel and Ortho Clinical Diagnostics, combining expertise in rapid testing and laboratory diagnostics. This chart shows employment in the medical diagnostics sector, which has accelerated since the pandemic and continues to grow amid demand for accurate and rapid testing.
Number of employees in the market as a whole
QuidelOrtho is a company specializing in diagnostic solutions, from rapid flu and COVID-19 tests to sophisticated laboratory equipment. Their business plays a key role in the healthcare system, enabling rapid and accurate diagnoses. Demand for their products is stable and growing alongside the general focus on health, providing sustainable employment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company QuidelOrtho (QDEL)
QuidelOrtho is a major diagnostic test manufacturer. This chart illustrates the model of a mature medical device company. Moderate capitalization per employee is a balance between the value of intellectual property, production capacity, and the global commercial team needed to sell tests to hospitals and labs.
%20of%20the%20company%20QuidelOrtho%20(QDEL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-QuidelOrtho-QDEL&v=1772513692979 "Chart of market capitalization per employee (in thousands of dollars) of the company QuidelOrtho (QDEL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
QuidelOrtho (QDEL) is a merger company producing diagnostic solutions, ranging from rapid tests (including COVID-19) to large-scale laboratory equipment. This chart shows the industry average market capitalization per employee. It helps understand how the market values their diversified diagnostic portfolio and manufacturing capacity.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772513692981 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
QuidelOrtho Corporation develops and manufactures diagnostic tests. This chart shows the overall market performance metric. It helps evaluate a company in the healthcare sector whose products play a critical role in disease diagnosis.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513692995 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company QuidelOrtho (QDEL)
QuidelOrtho is a company that produces diagnostic equipment and tests (including COVID-19 tests). This chart shows how efficiently their factories and R&D department generate profit. This figure has likely declined since the pandemic, but it still reflects the profitability of the diagnostics business.
%20Chart%20QuidelOrtho%20(QDEL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-QuidelOrtho-QDEL&v=1772513693001 "Company Profit Per Employee (in thousands of dollars) Chart QuidelOrtho (QDEL)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
QuidelOrtho (QDEL) is a diagnostics giant (Covid tests, lab equipment). This chart shows the benchmark for Med-Analysis. The average profit per employee is high here. It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from blades (disposable consumables, software), generated by a small staff.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772513693008 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
QuidelOrtho is the result of the merger of Quidel (rapid tests, including COVID-19) and Ortho (laboratory diagnostics). This chart shows how well the company has performed since the merger. It reflects the profitability of their vast portfolio of diagnostic tests and equipment per combined staff.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513693023 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee QuidelOrtho (QDEL)
QuidelOrtho is a company that produces diagnostic equipment and tests. This chart reflects the dynamics of the medical diagnostics sector. It shows the demand for the company's products in hospitals and laboratories and how effectively its production meets this demand.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-QuidelOrtho-QDEL&v=1772513693025 "Sales chart per company employee QuidelOrtho (QDEL)")
Sales per employee in the market segment - Medanalysis
QuidelOrtho is a major player in the diagnostics industry, offering both rapid tests (COVID, flu) and sophisticated lab equipment. This chart shows the average revenue per employee in this segment. It helps assess how productive the company is in the global diagnostics market (R&D, manufacturing, sales) compared to its competitors.
Sales per employee for the market as a whole
QuidelOrtho is a major manufacturer of diagnostic solutions, from rapid COVID-19 tests to sophisticated lab equipment. This chart shows the productivity of their manufacturing and R&D teams. This metric reflects their ability to generate revenue from both bulk consumables and high-end analytical systems.
Short shares by company, segment and market as a whole
Shares shorted by company QuidelOrtho (QDEL)
QuidelOrtho is a company formed from the merger of a rapid test manufacturer (Quidel, known for its COVID tests) and a diagnostic equipment manufacturer (Ortho). The company is currently suffering from a sharp decline in demand for COVID tests. This chart shows the percentage of "bears" who don't believe the core business can compensate for this loss.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-QuidelOrtho-QDEL&v=1772513693080 "Short Shares Chart for the Company QuidelOrtho (QDEL)")
Shares shorted by market segment - Medanalysis
QuidelOrtho, the merger company, produces diagnostic tests for both labs (Ortho) and rapid diagnostics (Quidel), including COVID-19 tests. This chart shows the cumulative short position in the medical diagnostics sector. Its rise signals investor concerns about revenue stability post-pandemic or general pressure on test prices.
Shares shorted by the overall market
QuidelOrtho (QDEL) produces diagnostic tests. This Short_All chart shows systemic pessimism. When it rises, even "defensive" sectors like healthcare are sold off. This fear of a correction is weighing on QDEL, whose earnings (post-COVID) have become more vulnerable to hospital budgets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator QuidelOrtho (QDEL)
QuidelOrtho is a major player in the diagnostic testing space. The company experienced a boom during COVID-19 and is now seeking stable growth beyond the pandemic. This chart measures how investors view this "post-COVID" future. It shows when the stock is "oversold" amid falling demand for tests or "overbought" amid expectations for growth in the underlying diagnostics business.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-QuidelOrtho-QDEL&v=1772513693135 "RSI 14 indicator chart for the company's stock QuidelOrtho (QDEL)")
RSI 14 Market Segment - Medanalysis
QuidelOrtho is the merger of Quidel (rapid diagnostics, COVID tests) and Ortho Clinical Diagnostics (laboratory equipment). They are a major player in the in vitro diagnostics field. This chart reflects the overall sentiment in the medical testing and diagnostics sector, helping to assess how the market views the industry as a whole.
RSI 14 for the overall market
QuidelOrtho (QDEL), a diagnostic testing manufacturer, uses this chart as an indicator of hospital budgets. While tests (for flu and Covid) are always needed, during times of market panic and recession, hospitals may reduce purchases of "non-urgent" equipment or switch to cheaper tests, which puts pressure on QDEL's margins.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast QDEL (QuidelOrtho)
QuidelOrtho (QDEL) is a diagnostics company that produces both rapid tests (Quidel) and large-scale lab equipment (Ortho). This chart shows the average 12-month forecast from analysts. It reflects their assessment of baseline demand for tests (non-COVID) and the success of the integration of the two businesses.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-QDEL-QuidelOrtho&v=1772513693173 "A chart showing analyst consensus forecasts for the expected stock price. QDEL (QuidelOrtho)")
The difference between the consensus estimate and the actual stock price QDEL (QuidelOrtho)
QuidelOrtho (QDEL), formed by the merger, is a major player in diagnostics. Its business consists of stable hospital tests and volatile at-home tests (like those for COVID). This chart shows the difference between the consensus estimate and the price. It reflects whether analysts believe the company can grow beyond COVID-19.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-QDEL-QuidelOrtho&v=1772513693179 "A chart showing the difference between the consensus forecast and the actual stock price. QDEL (QuidelOrtho)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
QuidelOrtho is a major player in the in vitro diagnostics field, formed through the merger of Quidel (rapid tests) and Ortho Clinical Diagnostics (laboratory equipment). This chart shows general expectations for the medical testing sector and reflects whether experts believe in the synergies of this merger.
Analysts' consensus forecast for the overall market share price
QuidelOrtho is a merger company that produces diagnostic tests (including COVID-19 tests) and equipment for laboratories and blood banks. This chart shows overall market sentiment. For QuidelOrtho, whose healthcare business is considered defensive, overall optimism is important, but investors are also monitoring demand for testing after the pandemic.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index QuidelOrtho
QuidelOrtho is a merged company that has become a diagnostics giant. Quidel brought rapid tests (COVID-19, flu), and Ortho brought powerful hospital lab equipment (blood tests). This chart evaluates their synergies, weighing the sharp decline in COVID testing revenue against the stable, long-term hospital lab services business.
AKIMA Market Segment Index - Medanalysis
QuidelOrtho (QDEL) is a global diagnostics giant (the result of the merger of Quidel and Ortho); the company produces a full range of tests, from rapid flu tests (POCT) to large-scale laboratory machines. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does QDEL's diversified (POCT + labs) model differentiate it from the average competitor?
The AKIM Index for the overall market
QuidelOrtho is a large diagnostics company formed by the merger of Quidel and Ortho Clinical. It produces tests for labs and home use. This chart, reflecting the market average, is a backdrop. It helps assess how this "protective" business, which is returning to normal after the pandemic, compares to general macroeconomic fluctuations.
